Jazz buys Celator for $1.5bn

01-06-2016

Jazz buys Celator for $1.5bn

Rrraum / Shutterstock.com

Jazz Pharmaceuticals, based in Ireland, will buy US company Celator Pharmaceuticals for $1.5 billion in cash.


Jazz Pharmaceuticals, Celator Pharmaceuticals, AML, oncology, mergers and acquisitions, Vyxeos

LSIPR